Entry	Length	Metal binding	Nucleotide binding	Cofactor	Binding site	Active site	Entry name	Gene names	Organism	Absorption	Activity regulation	Calcium binding	Catalytic activity	DNA binding	EC number	Function [CC]	Kinetics	Pathway	pH dependence	Redox potential	Rhea Ids	Site	Temperature dependence	Annotation	Caution	Features
Q695T7	634						S6A19_HUMAN	SLC6A19 B0AT1	Homo sapiens (Human)							FUNCTION: Transporter that mediates resorption of neutral amino acids across the apical membrane of renal and intestinal epithelial cells (PubMed:18424768, PubMed:18484095, PubMed:19185582, PubMed:26240152). This uptake is sodium-dependent and chloride-independent (PubMed:19185582, PubMed:15286788). Requires CLTRN in kidney or ACE2 in intestine for cell surface expression and amino acid transporter activity (PubMed:19185582, PubMed:18424768). {ECO:0000269|PubMed:15286788, ECO:0000269|PubMed:18424768, ECO:0000269|PubMed:18484095, ECO:0000269|PubMed:19185582, ECO:0000269|PubMed:26240152}.								5 out of 5		Chain (1); Glycosylation (5); Modified residue (2); Natural variant (16); Topological domain (13); Transmembrane (12)
Q9BYF1	805	METAL 374;  /note="Zinc; catalytic"; METAL 378;  /note="Zinc; catalytic"; METAL 402;  /note="Zinc; catalytic"		COFACTOR: Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000269|PubMed:11815627};  Note=Binds 1 zinc ion per subunit. {ECO:0000269|PubMed:11815627}; COFACTOR: Name=chloride; Xref=ChEBI:CHEBI:17996; Evidence={ECO:0000269|PubMed:11815627};  Note=Binds 1 Cl(-) ion per subunit. {ECO:0000269|PubMed:11815627};	BINDING 169;  /note="Chloride"; BINDING 273;  /note="Substrate"; BINDING 345;  /note="Substrate"; BINDING 346;  /note="Substrate; via carbonyl oxygen"; BINDING 371;  /note="Substrate"; BINDING 477;  /note="Chloride"; BINDING 481;  /note="Chloride"; BINDING 515;  /note="Substrate"	ACT_SITE 375; ACT_SITE 505	ACE2_HUMAN	ACE2 UNQ868/PRO1885	Homo sapiens (Human)		ACTIVITY REGULATION: Activated by chloride and fluoride, but not bromide. Inhibited by MLN-4760, cFP_Leu, and EDTA, but not by the ACE inhibitors linosipril, captopril and enalaprilat. {ECO:0000269|PubMed:10924499, ECO:0000269|PubMed:10969042, ECO:0000269|PubMed:11815627, ECO:0000269|PubMed:15231706}.		CATALYTIC ACTIVITY: Reaction=angiotensin II + H2O = angiotensin-(1-7) + L-phenylalanine; Xref=Rhea:RHEA:26554, ChEBI:CHEBI:15377, ChEBI:CHEBI:58095, ChEBI:CHEBI:58506, ChEBI:CHEBI:58922; EC=3.4.17.23;		3.4.17.23	FUNCTION: Carboxypeptidase which converts angiotensin I to angiotensin 1-9, a peptide of unknown function, and angiotensin II to angiotensin 1-7, a vasodilator (PubMed:10969042, PubMed:10924499, PubMed:11815627). Also able to hydrolyze apelin-13 and dynorphin-13 with high efficiency (PubMed:11815627). By cleavage of angiotensin II, may be an important regulator of heart function (PubMed:10969042, PubMed:10924499). By cleavage of angiotensin II, may also have a protective role in acute lung injury (By similarity). Plays an important role in amino acid transport by acting as binding partner of amino acid transporter SL6A19 in intestine, regulating trafficking, expression on the cell surface, and its catalytic activity (PubMed:18424768, PubMed:19185582). {ECO:0000250|UniProtKB:Q8R0I0, ECO:0000269|PubMed:10924499, ECO:0000269|PubMed:10969042, ECO:0000269|PubMed:11815627, ECO:0000269|PubMed:18424768, ECO:0000269|PubMed:19185582}.; FUNCTION: (Microbial infection) Acts as a receptor for SARS coronavirus/SARS-CoV. {ECO:0000269|PubMed:14647384, ECO:0000269|PubMed:15452268, ECO:0000269|PubMed:15791205, ECO:0000269|PubMed:24227843}.; FUNCTION: (Microbial infection) Acts as a receptor for Human coronavirus NL63/HCoV-NL63. {ECO:0000269|PubMed:15897467}.	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=6.9 uM for angiotensin I {ECO:0000269|PubMed:11815627}; KM=2 uM for angiotensin II {ECO:0000269|PubMed:11815627}; KM=6.8 uM for apelin-13 {ECO:0000269|PubMed:11815627}; KM=5.5 uM for dynorphin-13 {ECO:0000269|PubMed:11815627}; 		BIOPHYSICOCHEMICAL PROPERTIES:  pH dependence: Optimum pH is 6.5 in the presence of 1 M NaCl. Active from pH 6 to 9. {ECO:0000269|PubMed:11815627};		RHEA:26554			5 out of 5		Active site (2); Alternative sequence (2); Beta strand (13); Binding site (8); Chain (2); Disulfide bond (3); Glycosylation (7); Helix (32); Metal binding (3); Mutagenesis (30); Natural variant (2); Region (5); Sequence conflict (3); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (12)
D5HJT4	1242						D5HJT4_BCHK3	S	Bat SARS coronavirus HKU3-7							FUNCTION: Spike protein S1: attaches the virion to the cell membrane by interacting with host receptor, initiating the infection. {ECO:0000256|HAMAP-Rule:MF_04099}.; FUNCTION: Spike protein S2': Acts as a viral fusion peptide which is unmasked following S2 cleavage occurring upon virus endocytosis. {ECO:0000256|HAMAP-Rule:MF_04099}.; FUNCTION: Spike protein S2: mediates fusion of the virion and cellular membranes by acting as a class I viral fusion protein. Under the current model, the protein has at least three conformational states: pre-fusion native state, pre-hairpin intermediate state, and post-fusion hairpin state. During viral and target cell membrane fusion, the coiled coil regions (heptad repeats) assume a trimer-of-hairpins structure, positioning the fusion peptide in close proximity to the C-terminal region of the ectodomain. The formation of this structure appears to drive apposition and subsequent fusion of viral and target cell membranes. {ECO:0000256|HAMAP-Rule:MF_04099}.						SITE 654..655;  /note="Cleavage";  /evidence="ECO:0000256|HAMAP-Rule:MF_04099"; SITE 784..785;  /note="Cleavage";  /evidence="ECO:0000256|HAMAP-Rule:MF_04099"		4 out of 5	CAUTION: Lacks conserved residue(s) required for the propagation of feature annotation. {ECO:0000256|HAMAP-Rule:MF_04099}.	Chain (2); Coiled coil (2); Disulfide bond (2); Domain (3); Motif (1); Region (3); Site (2); Topological domain (1); Transmembrane (1)
A0A2R3SV02	7092						A0A2R3SV02_CVHSA		Bat SARS-like coronavirus				CATALYTIC ACTIVITY: Reaction=ATP + H2O = ADP + H(+) + phosphate; Xref=Rhea:RHEA:13065, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:43474, ChEBI:CHEBI:456216; EC=3.6.4.13; Evidence={ECO:0000256|SAAS:SAAS01232775}; CATALYTIC ACTIVITY: Reaction=a ribonucleoside 5'-triphosphate + RNA(n) = diphosphate + RNA(n+1); Xref=Rhea:RHEA:21248, Rhea:RHEA-COMP:11128, Rhea:RHEA-COMP:11129, ChEBI:CHEBI:33019, ChEBI:CHEBI:61557, ChEBI:CHEBI:83400; EC=2.7.7.48; Evidence={ECO:0000256|SAAS:SAAS01198479};								RHEA:13065; RHEA:21248			3 out of 5		Compositional bias (1); Domain (6); Region (1); Transmembrane (11)
